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Abstract
Background: Autonomic dysregulation (also called diencephalic epilepsy) has been reported
following traumatic brain injuries (TBI). However, until now, postural tachycardia syndrome
(POTS) has not been reported as a long-term complication in patients who have suffered a TBI.
We report on a series of patients who developed POTS after suffering TBI.
Methods: Eight patients who were referred to our center had suffered TBI and developed
features of orthostatic intolerance following head trauma. The patients’ neurological, neuro-
surgical and autonomic data (charts and/or physician letters) were then carefully reviewed for
demographic characteristics, comorbid conditions, symptoms of orthostatic intolerance, medi-
cations and response to medication. These patients were diagnosed as having POTS, primarily
based on their clinical features and findings from the head-up tilt test (HUTT). The data
presented is observational and descriptive (percentages or means).
Results: Eight patients (seven of them women) aged 21–41 years had suffered from TBI and
had developed features of POTS. All had been normal with no symptoms prior to their TBI. All
patients experienced orthostatic dizziness, fatigue, palpitations and near syncope. Six patients
suffered from frank syncope. Six patients developed significant cognitive dysfunction, and three
developed a chronic pain syndrome following trauma. All of the patients reported severe limita-
tions to their daily activities and had been unable to keep their jobs, and two were housebound.
Six patients demonstrated a good response to therapy with various combinations of medication.
The symptoms of orthostatic intolerance and syncope improved with the initiation of medical
therapy, as well as their reported quality of life. Two patients failed to show any improvement
with various combinations of medications and tilt training, and continued to experience
orthostatic difficulties.
Conclusions: Postural tachycardia syndrome may, in some cases, be a late complication of
traumatic brain injury. (Cardiol J 2010; 17, 5: 482–487)
Key words: postural tachycardia syndrome, trauma, brain injury
483
Khalil Kanjwal et al., Postural tachycardia syndrome following traumatic brain injury
www.cardiologyjournal.org
Introduction
Traumatic brain injury (TBI) is a significant
cause of both mortality and permanent disability
each year in the United States. Nearly 1.4 million
people suffer from TBI in the United States annu-
ally [1]. Approximately 20% of all TBI cases occur
as a consequence of motor vehicle accidents (the
principal reason for hospitalization in TBI patients)
[2–4]. In addition to the well-documented effects
that TBI has on the somatic nervous system, trau-
matic injury may affect the autonomic nervous sys-
tem as well. Autonomic dysfunction after TBI may
manifest itself  in disturbances in heart rate, respi-
ratory rate, temperature regulation or sweating.
Some patients may also experience muscle spastic-
ity as well as abnormal posturing. These problems
have been called ‘diencephalic epilepsy’ and sym-
pathetic storms [5, 6]. The exact incidence of auto-
nomic dysfunction following TBI is unknown. How-
ever, of patients admitted to an intensive care unit
following TBI, the reported incidence of autonomic
dysfunction ranges anywhere from 8% to 33% [5, 6].
Symptoms of autonomic dysregulation in TBI have
been reported in the period immediately following
injury or in the early phases of recovery, with few
reports of long-term effects. Postural tachycardia
syndrome (POTS) is a subtype of autonomic dys-
regulation characterized by an excessive pool-
ing of blood in the lower extremities. Thus far,
POTS has not been reported as a long-term com-
plication in patients who have suffered from TBI.
We report a review of a group of patients who de-
veloped POTS as a long-term complication of TBI.
Methods
The study was a retrospective descriptive ana-
lysis of patients followed up at the University of
Toledo Medical Center. Our Institutional Review
Board approved the study. Patients were included
in this study if they developed POTS following
a head trauma. These patients were managed at dif-
ferent places for orthostatic symptoms; all of them
had suffered TBI in the past. They were seen in our
clinic primarily for a second opinion regarding dia-
gnosis and management options. These patients
were diagnosed as having POTS primarily based on
their history, clinical features and findings from
head upright tilt table testing (HUTT).
Criterion for diagnosis of POTS
Postural orthostatic tachycardia is defined as
symptoms of orthostatic intolerance (of greater than
six months duration) accompanied by a heart rate in-
crease of at least 30 beats/min (or a rate that exceeds
120 beats/min) that occurs in the first ten minutes
of upright posture or HUTT occurring in the absence
of other chronic debilitating disorders. Symptoms in-
clude: fatigue, orthostatic palpitations, exercise in-
tolerance, lightheadedness, diminished concentra-
tion, headache, near syncope and syncope [7–12].
HUTT protocol
The protocol used for tilt table testing has been
described elsewhere, but basically our testing con-
sisted of a 70-degree baseline upright tilt for a pe-
riod of 30 minutes, during which heart rate and
blood pressure were monitored continually. If no
symptoms occurred, the patient was lowered to the
supine position and an intravenous infusion of iso-
proterenol started, with a dose sufficient to raise
the heart rate to 20–25% above the resting value.
Upright tilt was then repeated for a period of
15 minutes. Patients were included in the study if
they had a POTS pattern on HUTT (rise in heart
rate without any change in blood pressure) [7–12].
The treatment protocols employed were based on
our previous experiences with orthostatic disorders
and are described in detail elsewhere [7–12].
A total of eight patients who were referred to
our center suffered TBI and developed features of
orthostatic intolerance following head trauma. Pa-
tients’ neurological, neurosurgical and autonomic
data (charts and/or physician letters) were then
carefully reviewed for demographic characteristics,
comorbid conditions, symptoms of POTS, medica-
tions and response to medication. The time from
the injury to the development of symptoms was also
recorded. The data presented is observational and
descriptive (percentages or means)
Results
Eight patients (seven women and a man, aged
21–41) were identified as having suffered TBI and
subsequently developed POTS. Six of them were
Caucasian. The results are summarized in Table 1.
Nature of injury
Seven patients suffered TBI in motor vehicu-
lar accidents and one patient suffered a closed head
injury due to blunt trauma from a freight elevator.
Two patients received brain and neck injury follow-
ing motor vehicular accidents. Five patients suf-
fered such severe closed head injuries (intracere-
bral hemorrhage) that they required admission to
an intensive care unit.
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Onset of symptoms
The onset of orthostatic symptoms was insi-
dious in each patient. There was no record of acute
autonomic dysfunction recorded in any of the pa-
tients during their initial hospitalization. The time
from TBI to the onset of symptoms of POTS (as
recorded from the charts, physician letters and oth-
er communications) ranged from three months to
three years. During this period (from TBI to onset
of POTS symptoms), six patients had also devel-
oped cognitive dysfunction and three developed
chronic pain syndrome.
All patients had recovered from their TBI and
all were initially sent to rehabilitation centers. All
patients successfully completed the acute rehabili-
tation programs, and each reported having resumed
normal activities.
Symptoms of POTS
After a successful recovery from TBI, and com-
pleting an acute rehabilitation program. all eight
patients later developed symptoms of orthostatic
intolerance. The onset in each patient was slow and
insidious. The time from TBI to onset of these
symptoms as reported by the patients and in the
physician letters and communications ranged from
three months to three years. All patients reported
that the episodes of orthostatic intolerance were
frequent (two to four episodes over six months).
The description of these episodes was similar in
each patient. All patients experienced a cold-like
sensation followed by feelings of extreme fatigue,
lightheadedness, palpitations and presyncope while
upright which was relieved by recumbency. Six
patients developed frank syncope.
Each of these patients demonstrated a rise in
pulse rate of > 30 bpm from sitting to standing po-
sition (n = 5) and an absolute rise in heart rate
> 120 bpm (n = 3) within ten minutes of assuming
an upright posture.
Head-up tilt test
All eight patients underwent HUTT. All pa-
tients demonstrated either an absolute heart rate
Table 1. Clinical characteristics of patients with postural tachycardia syndrome (POTS) following
traumatic brain injury.
Pt # 1 2 3 4 5 6 7 8
Age at onset of trauma 38 36 39 35 41 38 37 21
Time to onset of POTS 2 years 2 years 2 years 3 years 2 years 3 years 3 months 3 months
Sex F F F F F F M F
Race NK C C C C C C C
Type of trauma MVA MVA MVA MVA Hit by freight MVA MVA MVA
 elevator
Brain injury Closed Closed Closed Closed Closed Closed Closed/ Closed/
/neck /neck
ICU requirement Yes No Yes No Yes Yes No Yes
Syncope Yes No Yes Yes Yes No Yes Yes
Near syncope Yes Yes Yes Yes Yes Yes Yes Yes
Orthostatic palpitations Yes Yes Yes Yes Yes Yes Yes Yes
Dizziness Yes Yes Yes Yes Yes Yes Yes Yes
Fatigue Yes Yes Yes Yes Yes Yes Yes Yes
Chronic pain syndrome Yes No Yes No No No Yes No
Cognitive dysfunction Yes No Yes No Yes Yes Yes Yes
Medications:
Beta-blockers No No No Yes No Yes No Yes
Pyridostigmine No Yes Yes No No No No Yes
Midodrine Yes No Yes No Yes Yes Yes No
Fludrocortisone No Yes No No Yes No No No
Modefinil Yes No No No Yes No No No
Cerefolin Yes No Yes No Yes Yes Yes Yes
SSRI No No Yes Yes Yes Yes Yes Yes
Response to therapy Good Good Good Good Poor Poor Good Good
F — female; M — male; NK — not known; C — Caucassian; MVA — motor vehicular accidents; ICU — intensive care unit; SSRI — serotonin reuptake
inhibitor
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> 120 bpm or an increase by > 30 bpm within the
first ten minutes of an upright tilt. There was a vari-
able degree of fall in blood pressure associated with
symptoms of orthostatic intolerance, similar to that
reported during their spontaneous episodes. None
of the patients had a resting heart rate > 100 bpm.
We did not routinely evaluate catecholamine le-
vels in any of these patients.
Activities of daily living
All patients reported having severe limitations
in activities of daily living. In addition, each patient
reported loss of employment, and two were com-
pletely housebound.
Management
Following recognition of POTS in these pa-
tients, they were treated with a variety of medica-
tions (Table 1). No drug is presently approved by
the US Food and Drug Administration for the treat-
ment of POTS, and the treatments listed here are
all ‘off label’.
The therapeutic management approach for
these patients was based on our experience of the
management of patients with POTS [8–13]. In pa-
tients suffering from the partial dysautonomic form
of POTS, initial therapy is directed at augmenting
fluid volume and increasing peripheral vascular re-
sistance. To augment volume, we employ the min-
eral corticoid fludrocortisone acetate, starting at
0.1 to 0.2 mg per day. An alternative agent is desmo-
pressin acetate 0.1 to 0.2 mg orally at bedtime. If
needed, we then add a vasoconstrictor such as mi-
dodrine 5 mg orally three to four times daily. The
dose may be slowly shifted up to 10 to 15 mg QID if
necessary. As many patients are most symptomat-
ic in the morning, we often advise that they take
their first dose of midodrine 15 to 20 minutes be-
fore getting out of bed. If midodrine is effective but
not tolerated, methylphenidate can be an effective
alternative. In patients who are not responsive to,
or intolerant of, the above-mentioned therapies, we
often add either a serotonin reuptake inhibitor
(SSRI) or a norepinephrine reuptake inhibitor.
Whereas the SSRIs are more helpful in neurocar-
diogenic syncope, the norepinephrine reuptake in-
hibitors appear to be somewhat more useful in
POTS. If an SSRI is used, those with a combined
serotonin norepinephrine effect (duloxetine and
venlafaxine) appear to work best. A promising new
therapy is pyridostigmine (mestinon), an acetylcho-
linesterase inhibitor that is thought to facilitate
ganglionic neural transmission in both the sympa-
thetic and parasympathetic nerves [14]. The drug
appears most effective in patients with post-viral
POTS, as well as in those with POTS secondary to
an autoimmune disorder (such as lupus or Sjögren
syndrome). We usually start with a dose of 30 mg
orally BID and titrate to 60 to 90 mg orally three
times a day if necessary. In patients who are severe-
ly affected by POTS and in whom no other therapy
is effective or tolerated, we use the drug erythro-
poietin. Although initially introduced to treat ane-
mia, erythropoietin has been found to process po-
tent vasoconstrictive effects with demonstrated
utility in treating orthostatic disorders. Protocols
for its use are given elsewhere [13]. The usual start-
ing dose is 10 000 IU subcutaneously once weekly.
Complete blood counts are monitored monthly to
ensure that the hematocrit does not exceed 50%.
An additional therapy for refractory patients is
the somatostatin analog octreotide, because of its
potent vasoconstrictive effects. It is administered
by subcutaneous injection beginning at 50 mg two
to three times daily.
In the hyperadrenergic form of POTS, patients
often respond best to agents that block norepine-
phrine or its effects. One agent that is particularly
helpful is clonidine HCI in either pill or patch form.
We start the oral form at 0.1 mg PO one to two times
a day and filtrate upward. The patch form of cloni-
dine is quite useful because it provides a constant
and continuous amount of the drug for up to one
week at a time. The combined alpha and beta block-
ing drugs labetalol and carvedilol are quite useful
in some patients because pure beta blockers may
exacerbate symptoms (because of unopposed alpha
receptor stimulation). Methyldopa has been report-
ed to be useful in some patients, as has phenobar-
bital. In addition, both the SSRIs and norepineph-
rine reuptake inhibitors are useful in select patients.
Six patients demonstrated a good response to
therapy with various combinations of medications.
The symptoms of orthostatic intolerance and syn-
cope improved with initiation of medical therapy,
as well as their reported quality of life. Two patients
failed to show any improvement with various com-
binations of medications and tilt training, and con-
tinued to experience orthostatic difficulties.
Discussion
Disturbances of the autonomic nervous system
(ANS) are well-recognized complications of TBI. In
the acute period following TBI, autonomic dysfunc-
tion is manifested by a period of intense sympathetic
hyperactivity, resulting in hypertension, fever, and
tachycardia extensor posturing (dystonia) [14–17].
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These symptoms often begin five to seven days af-
ter injury and may last anywhere from two weeks
to several months. It is felt that this phase of the
autonomic dysregulation occurs from injury to one
or more aspects of the brain that normally control
the autonomic nervous system. These areas poten-
tially include the cortical aspects of the anterior
temporal, insular and orbitofrontal regions that in-
fluence the hypothalamus.
Additionally damage to the subcortical areas of
the nucleus tractus solitarious and the amygdala
may also cause hypothalamic damage resulting in
a state of autonomic dysregulation [18–21].
To date, there have been no reports of late as-
pects of autonomic dysfunction resulting in orthos-
tatic intolerance following TBI. Postural tachycar-
dia syndrome is a type of autonomic dysfunction
syndrome usually manifested by excessive ortho-
static blood pooling with a compensatory tachycar-
dia. The usual definition of POTS is a greater than
30 beats/minute increase in heart rate (or a total of
a rate of greater than 120 beats/min) that occur in
the first ten minutes of upright posture not associ-
ated with other conditions that could simulate this
effect, such as prolonged bed rest (greater than
three months duration) [7–13].
The current study describes a group of patients
who appear to have developed POTS as a late com-
plication of TBI. None of the patients reported here
had any symptoms of POTS prior to TBI. The oth-
er reported conditions that seem to provoke POTS,
such as severe viral infections and pregnancy, were
not present in any of the patients described in this
series. The only event temporally related to the
development of their POTS was the TBI. No patient
in this series was reported to have developed acute
autonomic dysregulation in the early phases follow-
ing their injury. The clinical features of the group
of patients described here with post-traumatic
POTS appear for the most part identical to POTS
patients in general. While the majority of patients
in our study improved with therapy, two patients
have continued to suffer disabling symptoms de-
spite all treatment attempts. At this point, it is un-
clear why patients who have suffered from a TBI
would develop POTS, or if their long-term out-
comes will be different from other POTS patients
in general. Close follow-up of these patients over
time will help clarify this.
Limitations of the study
Our study was limited by the fact that it was
a single center, retrospective observational study
of a small group of patients. The information on
symptoms and their severity was based on patient
reporting as recorded from the patient charts and
physician communications. Another limitation of the
current study is that the catecholamine levels were
not checked. The response to the therapy was not
objectively measured with a HUTT; rather, thera-
py was assessed by patient-reported symptoms and
clinical observation. The estimation of the time from
TBI to onset of symptoms was determined from
patient interviews and referring physicians’ com-
munications and would be limited by a recall bias.
Also, no other markers of autonomic dysfunction
were evaluated in this small group of patients.
Despite all these limitations, the reported se-
ries of patients had a common pattern of TBI fol-
lowed by later symptoms of orthostatic intolerance.
A prospectively designed study following patients
who suffer from TBI may provide a better insight
into unresolved issues that this report could not
address.
Conclusions
Postural tachycardia syndrome may, in some
cases, be a late complication of traumatic brain injury.
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